Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Six pharma stocks that should be on your radar today over various news triggers
It was a busy weekend for pharma stocks as four of them — Divi's Laboratories, Fortis Healthcare, Torrent Pharma and Narayana Hrudayalaya — reported their quarterly results. Meanwhile, Lupin marked its entry into the Chinese market, while Glenmark Pharma's US arm settled an anti-trust litigation. Here's a look at these names in detail:
Fortis Healthcare consolidated net profit rises 44.57% in the March 2026 quarter
Sales rise 17.81% to Rs 2364.67 crore
Fortis liability case: Delhi HC says blame can't be shifted to third party
Amid ongoing legal disputes, the Delhi High Court is probing Fortis Healthcare's oversight concerning the sale of shares belonging to the Singh brothers, former promoters of the company. The court's remarks suggest that Fortis had a responsibility to inhibit such transactions.
Fortis Healthcare Q4 profit up 45% on lower exceptional losses, higher revenue
The board recommended a final dividend of ₹1 per equity share of face value ₹10 each for FY26. Shares of Fortis Healthcare Limited ended ₹5.40 lower at ₹961.90 on the NSE today, May 22.
Q4 Results Live Updates: Sun Pharma Revenue Up 12%; IRCON Profit Falls 10%
Key companies in focus include Sun Pharma, NTPC Green Energy, Hindalco Industries, Eicher Motors, Colgate-Palmolive (India), Fortis Healthcare and 3M India.
Q4 Results LIVE Updates: Max Health shares decline 7%, Honasa Consumer up 7%; Hindalco report today
Q4 Results Live Update: Another busy earnings week ends with three Nifty names - Sun Pharma, Eicher Motors and Hindalco reporting their results today, along with broader market names like Torrent Pharma, Fortis Healthcare, DAM Capital, Colgate-Palmolive, IRCON International, Jubilant Pharmova, Minda Corp, and many others. LG, LIC, GAIL, ITC, will also be reacting to their results reported on Thursday.
Stocks to buy for short term: Bharat Forge, Fortis Health - Ajit Mishra of Religare Broking suggests 3 stock picks
Ajit Mishra from Religare Broking identifies three stocks, including Bharat Forge and Fortis Healthcare, that show promise for short-term investors. With strategic breakouts and bullish patterns, these stocks could offer lucrative opportunities despite current market pressures.
IHH Healthcare aims to hike its stake in Fortis to 50%: CEO Prem Kumar Nair
IHH Healthcare sees India as a major growth market. The company plans to increase its stake in Fortis Healthcare. IHH aims to expand its hospital bed count to 10,000 by 2030. Investments will focus on existing Fortis locations and integrating Gleneagles facilities. The group is also repositioning its diagnostics arm.
Stock market today: Trade setup for Nifty 50, Gift Nifty, US-Iran war to gold, silver rates — 7 stocks to buy or sell
Stocks to buy today: Experts have recommended buying these eight shares — UPL, Biocon, HDFC Life, Fortis Healthcare, Tata Technologies, Samman Capital, and MM Forging
Trade Spotlight: How should you trade Caplin Point, Max Health, Fortis Healthcare, Deepak Fertilisers, InterGlobe Aviation, and others on June 9?
Following the sharp sell-off, the market is expected to consolidate and trade in a range-bound manner. Below are some short-term trading ideas to consider.
Buy Fortis Healthcare; target of Rs 1120: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Fortis Healthcare has recommended buy rating on the stock with a target price of Rs 1120 in its research report dated May 26, 2026.